Meet
Clare Jones
Executive Director, Global Market Access
Authored Content
Given the uncertain challenge of future international price referencing by the US, Avalere Health considers implications for global market access.
New Avalere Health research explores the challenges and potential opportunities for demonstrating the value of cancer drugs to HTA agencies.
New research highlights the market access risks faced by manufacturers who use less traditional outcome measures to demonstrate value of innovative hemato-oncology therapies.